Healthcare IT Today
OCTOBER 24, 2024
. “Our collaboration with the Association will create valuable opportunities for thousands of members to engage with industry, apply their expertise in new roles, and shape the future of healthcare technology.” MDisrupt has raised $6.6 million to date, including its most recent $3 million in seed funding.
Lloyd Price
FEBRUARY 7, 2025
Nelson Advisors Healthcare Technology > Mergers, Acquisitions, Growth, Strategy, Investments [link] We work with Healthcare Technology founders, owners and investors to assess whether they should 'Build, Buy, Partner, Invest or Sell' in order to maximise shareholder value and investment returns.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
APRIL 25, 2024
About Koneksa Koneksa is a healthcare technology company pioneering evidence-based digital biomarkers to accelerate clinical research and guide decision-making in drug development and market strategy. Acute toxicities of RT/CRT for lung cancer commonly include fatigue, dermatitis, esophagitis, and respiratory symptoms.
Lloyd Price
MARCH 1, 2025
Big Pharmas looming patent cliffs could drive outlier deals (7-8x or more) for late-stage innovators, especially in biotech-adjacent HealthTech. in 2023 but still higher than the average revenue multiple for all technology companies, which is 3.5x. What are the biggest trends likely to affect healthcare technology multiples in 2025?
Lloyd Price
FEBRUARY 23, 2025
These figures highlight its ability to grow profitably, a rarity in healthcare IT, and its dominance in the digital physician market, which it expects to expand 5-7% annually, with Doximity aiming to outpace that. Comparatively, the healthcare sector has lagged in recent years, but 2025 is showing signs of a turnaround.
Lloyd Price
DECEMBER 2, 2024
By embracing technological advancements, focusing on personalised medicine, and addressing the challenges of chronic wounds, the industry can improve patient outcomes, reduce costs, and enhance the overall quality of care. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
Digital Health Global
AUGUST 2, 2023
Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He He has consistently worked to improve the speed, safety, and cost-effectiveness of clinical trials through the adoption of new technological solutions.
Expert insights. Personalized for you.
120 
Let's personalize your content